theory < therapeutic < therapeutics

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000004 (2020)		[Standardized management guideline for pediatric wards of hematology and oncology during the epidemic of coronavirus disease 2019].
000041 (2020)	J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine]	[Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000092 (2020)	Robert L. Kruse [États-Unis]	Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000093 (2020)	Phulen Sarma ; Manisha Prajapat ; Pramod Avti ; Hardeep Kaur ; Subodh Kumar ; Bikash Medhi	Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
000094 (2020)	Guangdi Li ; Erik De Clercq	Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
000115 (2020)	Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]	The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000139 (2020)	Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France]	Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?
000144 (2020)	Lan Zhu [République populaire de Chine] ; Xizhen Xu [République populaire de Chine] ; Ke Ma [République populaire de Chine] ; Junling Yang [République populaire de Chine] ; Hanxiong Guan [République populaire de Chine] ; Song Chen [République populaire de Chine] ; Zhishui Chen [République populaire de Chine] ; Gang Chen [République populaire de Chine]	Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.
000244 (2020)	Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine]	Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
000253 (2020)	Kollengode Ramanathan [Australie] ; David Antognini [Australie] ; Alain Combes [France] ; Matthew Paden [États-Unis] ; Bishoy Zakhary [États-Unis] ; Mark Ogino [États-Unis] ; Graeme Maclaren [Australie] ; Daniel Brodie [États-Unis] ; Kiran Shekar [Australie]	Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
000260 (2020)	Fang Liu [République populaire de Chine] ; Aifang Xu [République populaire de Chine] ; Yan Zhang [République populaire de Chine] ; Weiling Xuan [République populaire de Chine] ; Tingbo Yan [République populaire de Chine] ; Kenv Pan [République populaire de Chine] ; Wenyan Yu [République populaire de Chine] ; Jun Zhang [République populaire de Chine]	Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
000303 (2020)	Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde]	Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
000339 (2020)	P. Conti [Italie] ; G. Ronconi [Italie] ; A. Caraffa [Italie] ; C. Gallenga [Italie] ; R. Ross [États-Unis] ; I. Frydas [Grèce] ; S. Kritas [Grèce]	Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
000506 (2020)	B. Robson [États-Unis, Royaume-Uni]	Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
000529 (2020)	Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine]	Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
000573 (2020)	Dan Zhou [République populaire de Chine] ; Sheng-Ming Dai [République populaire de Chine] ; Qiang Tong [République populaire de Chine]	COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
000599 (2020)	Mazin Barry ; Maha Al Amri ; Ziad A. Memish	COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia.
000618 (2020)	John R. Greenland ; Marilyn D. Michelow ; Linlin Wang ; Martin J. London	COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.
000643 (2020)	Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine]	Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
000647 (2020)	Shibo Jiang [République populaire de Chine] ; Lanying Du [États-Unis] ; Zhengli Shi [République populaire de Chine]	An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.
000675 (2020)	Xiaoyu Han ; Yanqing Fan ; Yung-Liang Wan [Taïwan] ; Heshui Shi	A Diabetic Patient With 2019-nCoV (COVID-19) Infection Who Recovered and Was Discharged From Hospital.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i -k "therapeutic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i  \
                -Sk "therapeutic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    therapeutic
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021